June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Altered levels of aqueous humour soluble factors are associated with therapy-mediated resolution of macular edema in patients with Choroidal Neovascular Membranes
Author Affiliations & Notes
  • santosh gopi krishna Gopi Krishna gadde
    Vitreo Retina, Narayana Nethralaya, Bangalore, Karnataka, India
  • Priyanka Chevour
    GROW LAB, NARAYANA NETHRALAYA, BANGALORE, KARNATAKA, India
  • Shivani Sinha
    Vitreo Retina, Narayana Nethralaya, Bangalore, Karnataka, India
  • Rohit Shetty
    CORNEA AND REFRACTIVE SURGERY, NARAYANA NETHRALAYA, BANGALORE, KARNATAKA, India
  • Swaminathan Sethu
    GROW LAB, NARAYANA NETHRALAYA, BANGALORE, KARNATAKA, India
  • Arkasubhra Ghosh
    GROW LAB, NARAYANA NETHRALAYA, BANGALORE, KARNATAKA, India
  • Footnotes
    Commercial Relationships   santosh gopi krishna gadde, None; Priyanka Chevour, None; Shivani Sinha, None; Rohit Shetty, None; Swaminathan Sethu, None; Arkasubhra Ghosh, None
  • Footnotes
    Support  NARAYANA NETHRALAYA FOUNDATION
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2305. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      santosh gopi krishna Gopi Krishna gadde, Priyanka Chevour, Shivani Sinha, Rohit Shetty, Swaminathan Sethu, Arkasubhra Ghosh; Altered levels of aqueous humour soluble factors are associated with therapy-mediated resolution of macular edema in patients with Choroidal Neovascular Membranes. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2305.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Choroidal neovascularization membranes (CNVM), a progressive, advanced form of age-related macular degeneration results in vision loss. Varying response to intra-vitreal injection therapy has been observed. Hence, this study aims to determine the association between the levels of various soluble secreted factors in the aqueous humour and response of macular edema to therapy in CNVM patients.

Methods : Aqueous humour samples were collected from CNVM patients (n=31) undergoing intravitreal anti-VEGF after obtaining informed written consent and prior study approval by the Institutional Ethics Committee. The study subjects included CNVM patients (n=31) undergoing intravitreal anti-VEGF. Routine investigations including OCT imaging along with intravitreal injections were performed during visits. The subjects were then grouped as resolving edema (n=18) and persistent edema (n=8) based on the reduction in edema volume (analysed using MATLAB image processing) between two visits. Cytometric bead array was used for simultaneous quantification of IL-2, IL-4, IL-8, IL-17F, MCP-1, MIP-1β, CXCL9, CXCL10, CXCL11, Fractalkine, CD62L, CD62P, ICAM1, VCAM, Angiogenin and VEGF in aqueous humour collected during first visit.

Results : VEGF levels in aqueous humour was significantly (p=0.03) lower in the persistent edema group (66±13 pg/ml) compared to resolving edema group (249±92 pg/ml). A significant increase in the levels of ICAM1, VCAM, CD62L and CXCL10 were observed in the aqueous humour of those patients with persistent edema compared to those with resolving edema. A positive correlation was observed between difference in edema volume (between visits) and ICAM1 (r=0.550; p=0.003), VCAM (r=0.455; p=0.01), CD62L (r=0.537; p=0.004) and IL-2 (r=0.424; p=0.03). These observations suggest the possible role of soluble cell adhesion molecules in the response of macular edema to therapy in CNVM patients. In addition, the decreasing trend in central subfoveal thickness was greater in those with resolving edema compared to persistent edema.

Conclusions : The findings demonstrate a unique set of soluble factors in aqueous humour which may influence or indicate the status of therapy-mediated reduction of macular edema in CNVM patients.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×